Sexcord/ stromal ovarian tumors risk factors

Jump to: navigation, search

Sexcord/ stromal ovarian tumors Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sexcord/ stromal ovarian tumors risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sexcord/ stromal ovarian tumors risk factors

CDC on Sexcord/ stromal ovarian tumors risk factors

Sexcord/ stromal ovarian tumors risk factors in the news

Blogs on Sexcord/ stromal ovarian tumors risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Sexcord/ stromal ovarian tumors risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  ; Maneesha Nandimandalam, M.B.B.S.[2]

Overview

Common risk factors in the development of sexcord/ stromal ovarian tumors include preterm birth, high gonadotrophin levels, increasing age at first pregnancy, obese and non-white women

Risk Factors

There is very little data regarding the risk factors of sexcord-stromal ovarian tumors, however given below are some of the important risk factors for the development of sexcord-stromal ovarian tumors:[1][2][3][4][5]

References

  1. Sieh W, Sundquist K, Sundquist J, Winkleby MA, Crump C (May 2014). "Intrauterine factors and risk of nonepithelial ovarian cancers". Gynecol. Oncol. 133 (2): 293–7. doi:10.1016/j.ygyno.2014.02.007. PMC 4006291. PMID 24530563.
  2. Chen T, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Kaaks R, Koskela P, Grankvist K, Hallmans G, Pukkala E, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Lukanova A (February 2011). "Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer". Cancer Epidemiol. Biomarkers Prev. 20 (2): 324–36. doi:10.1158/1055-9965.EPI-10-0857. PMC 3082204. PMID 21177423.
  3. Horn-Ross PL, Whittemore AS, Harris R, Itnyre J (November 1992). "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian Cancer Group". Epidemiology. 3 (6): 490–5. PMID 1329996.
  4. Greggi S, Parazzini F, Paratore MP, Chatenoud L, Legge F, Mancuso S, La Vecchia C (October 2000). "Risk factors for ovarian cancer in central Italy". Gynecol. Oncol. 79 (1): 50–4. doi:10.1006/gyno.2000.5909. PMID 11006030.
  5. Zheng G, Yu H, Kanerva A, Försti A, Sundquist K, Hemminki K (2018). "Familial risks of ovarian cancer by age at diagnosis, proband type and histology". PLoS ONE. 13 (10): e0205000. doi:10.1371/journal.pone.0205000. PMC 6169923. PMID 30281663.
  6. Boyce EA, Costaggini I, Vitonis A, Feltmate C, Muto M, Berkowitz R, Cramer D, Horowitz NS (November 2009). "The epidemiology of ovarian granulosa cell tumors: a case-control study". Gynecol. Oncol. 115 (2): 221–5. doi:10.1016/j.ygyno.2009.06.040. PMID 19664811.

Linked-in.jpg